The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty
PurposeThe effects of gonadotropin-releasing hormone agonist (GnRHa) treatment on body mass index (BMI) are controversial in girls with central precocious puberty (CPP). We therefore evaluated auxological parameters during GnRHa therapy in patients with CPP, specifically focusing on changes in BMI.M...
Main Authors: | Won Jun Yang, Keun Hyeok Ko, Kon Hee Lee, Il Tae Hwang, Yeon Joung Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pediatric Endocrinology
2017-03-01
|
Series: | Annals of Pediatric Endocrinology & Metabolism |
Subjects: | |
Online Access: | http://e-apem.org/upload/pdf/apem-22-49.pdf |
Similar Items
-
Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
by: Hye Ryun Kim, et al.
Published: (2017-12-01) -
The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
by: Jong Wan Yoon, et al.
Published: (2017-12-01) -
Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
by: Min Jin Jeon, et al.
Published: (2021-09-01) -
Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty
by: Ahmet Anik, et al.
Published: (2015-01-01) -
Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
by: Lindsey Yoojin Chung, et al.
Published: (2020-06-01)